Jan 22
|
Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?
|
Jan 21
|
Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’
|
Jan 21
|
Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?
|
Jan 21
|
Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company
|
Jan 20
|
Bristol-Myers Squibb Company (BMY): A Bull Case Theory
|
Jan 18
|
Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?
|
Jan 18
|
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
|
Jan 4
|
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
|
Jan 3
|
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
|
Jan 3
|
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025
|
Jan 2
|
Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years
|
Dec 31
|
Corcept Submits Application for Another Cushing's Syndrome Drug
|
Dec 31
|
Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?
|
Dec 31
|
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
|
Dec 30
|
Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?
|
Dec 30
|
FDA approves BMS’ Opdivo Qvantig for solid tumour indications
|
Dec 29
|
Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year
|
Nov 1
|
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
|
Nov 1
|
Company News for Nov 1, 2024
|
Nov 1
|
Bristol-Myers Squibb Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|